Upgrade to SI Premium - Free Trial

Sarepta (SRPT) PT Raised to $58 at Jefferies

October 3, 2016 6:42 AM
Jefferies analyst Gena Wang reiterated a Hold rating but lifted her price target on Sarepta Therapeutic (NASDAQ: SRPT) to $58.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles